Cart
sales@molnova.com
DNQX Disodium
CAS No. 1312992-24-7
DNQX Disodium( —— )
Catalog No. M21938 CAS No. 1312992-24-7
DNQX Disodium is a water-soluble form of selective antagonist of non-NMDA receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 119 | In Stock |
|
| 5MG | 119 | In Stock |
|
| 10MG | 181 | In Stock |
|
| 25MG | 297 | In Stock |
|
| 50MG | 410 | In Stock |
|
| 100MG | 554 | In Stock |
|
| 200MG | 736 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDNQX Disodium
-
NoteResearch use only, not for human use.
-
Brief DescriptionDNQX Disodium is a water-soluble form of selective antagonist of non-NMDA receptor.
-
DescriptionDNQX Disodium is a water-soluble form of selective antagonist of non-NMDA receptor.
-
In VitroDNQX (FG 9041) disodium salt selectively depolarizes thalamic reticular nucleus (TRN) neurons.
-
In VivoDNQX (FG 9041), a specific AMPA receptor antagonist, given as either a 5 mg/kg or 10 mg/kg intraperitoneal dose or into the lateral cerebral ventricle (5 μl of 0.5 mg/ml) significantly diminishes phencyclidine (PCP) (40 mg/kg) and ketamine (80, 100, 120 mg/kg) hsp70 induction in the posterior cingulate and retrosplenial cortex.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptornon-NMDA
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1312992-24-7
-
Formula Weight296.1
-
Molecular FormulaC8H2N4Na2O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[Na+].[Na+].[O-]c1nc2cc(c(cc2nc1[O-])[N+]([O-])=O)[N+]([O-])=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lee S H , Govindaiah G , Cox C L . Selective Excitatory Actions of DNQX and CNQX in Rat Thalamic Neurons[J]. Journal of Neurophysiology, 2010, 103(4):1728-1734.
molnova catalog
related products
-
Peanutprocyanidin F
Peanutprocyanidin F
-
Lupartumab
Lupartumab (BAY 1112623) is a monoclonal antibody targeting LYPD3 (C4.4A) and is employed in the synthesis of antibody-active molecular couplers for studying LYPD3-associated tumor diseases.
-
Flavanone
Used as organic synthesis and medicine intermediate.
